These results also suggested that elevated levels of adiponectin would be associated with a reduced risk of primary liver cancer linked with obesity, and that hyperadiponectinemia might suppress liver tumorigenesis (Wieser et al., 2012). Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.